Articles Posted in Orange County Medical Marijuana Dispensaries

Regulators of California’s marijuana industry want to put a stop on so-called “laboratory shopping” by growers and retailers. The practice reportedly involves cannabis companies being drawn to working with testing sites that have a reputation for landing on higher THC concentrations in marijuana products, thus allowing those goods to be sold at a premium.Los Angeles cannabis testing

As our Los Angeles cannabis business lawyers can explain, while the state has clear guidelines in place mandating marijuana products be screened for contaminants and THC content by licensed testing facilities, what is lacking is any sort of uniform methodology to do so. The result of that is that two facilities may be using different processes, ultimately leading to a variation of findings.

Products with a greater THC concentration (which has the greatest potential for intoxication) are going to be in higher demand. The state’s problem is a pattern it has identified of marijuana growers shopping around for labs that employ testing methods that have a greater tendency to indicate a higher THC concentration.

In an effort to drill down on this matter, the state’s Department of Cannabis Control recently initiated the process of rulemaking that would ultimately lead to development of a standard test method that would need to be adopted by all licensed cannabis testing labs. The state agency’s director said this issue comes about partially as a result of regulating an industry that lacks federal recognition, and thus has no standard, validated testing methods. Licensed labs have reportedly issued THC concentration data that may be inconsistent – or possibly even inaccurate – according to the agency. Having a streamlined testing process, the agency said in a press release, will improve testing accuracy, stakeholder confidence, and market integrity.

Public comment on the proposed testing method rules is being accepted through July, with a public hearing scheduled for the first day of August. Continue reading

medical marijuana attorneyAs of March 1, 2020, California has allowed qualified medical marijuana patients and primary caregivers to receive free cannabis, donated by retailers. This welcomed update arose after the passing of Senate Bill 34, which is also responsible for exempting donated cannabis items from cultivation, sales and use, and excise taxes.

The bill states licensed growers, distributors, manufacturers, retailers and micro-businesses may allocate any already available inventory of cannabis and related marijuana products, for donation. Products set aside for donation can only be given by licensed retailers either directly to a medical patient, or to their primary caregiver.

Continue reading

California’s cannabis industry is sitting on a not-so-well kept secret — that many of its licensed, above board, legal business operators have also traded unlawfully, at some point, and to one extent or another.marijuana business

As many industry insiders have echoed, anyone turning a profit in this new era, has to have at least one hand in unregulated dealings. Chris Coulombre, CEO of Pacific Expeditors in Sonoma, has said “I have to imagine that 60 percent of the market overall is probably playing in a parallel markets, but I don’t think they enjoy that. It’s truly a decision of necessity.”

Whispers of retailers selling counterfeit products are rife. Cultivators are known to sell unregulated product on the side. But how can we blame them? Suffering terribly at the hands of price undercutting from illegal competitors, these unregulated exchanges are all taking place in hopes of keeping doors open, and businesses afloat. Continue reading

The issue of children and marijuana protections arose once again in the form of a proposed bill from Californiamedical marijuana Senator Jean Fuller (R-Bakersfield). The senator wanted to get on the books more concrete ramifications for dispensaries who sold marijuana to underage clients. The bill proposed a tiered system in which first offenders would receive a 15-day license suspension, second-time offenders within a three-year period would receive a 25-day suspension, and a third offense in three years would lead to a full license revocation. SB-1451, however, was vetoed by Gov. Jerry Brown, who called the bill “not necessary,” according tot a report from High Times. Gov. Brown pointed to the Bureau of Cannabis Control and cited their power to suspend or revoke licenses based on these exact kinds of violations and said he would rather the bureau be able to use their own discretion in determining punishment.

In the numerous discussions surrounding the issue of cannabis laws in California and other states across the country, there has been an extraordinary amount of focus on children. Can they be recommended marijuana by a doctor? What is the punishment for selling to a minor? How can marijuana businesses advertise in a way that would not be seen by or not be appealing to children? How do we make the packaging child safe? How does cannabis affect developing brains and bodies? How far should a business be located from schools? The list goes on and on, and many of these issues can be addressed simply with the guidance of a skilled marijuana legal counsel. Continue reading

Recent research out of American University, Colorado State University, and Montana State University delved into a medical marijuanacorrelation between workplace fatalities and the legalization of medical marijuana, and the discoveries could be surprising to many. The data points compiled fly in the face of anti-marijuana rhetoric that has been peddled as “common sense” for decades and show, in fact, a sharp decline in fatal workplace accidents as access to medical marijuana increases. The research is set to be published in The International Journal of Drug Policy, and according to a report from Colorado Springs Independent, the connection the research demonstrated between continuous decreases in fatalities in the workplace and medical marijuana is compelling.

Researchers compiled data from 1992 to 2015, providing a set that included the several years leading up to the passage of the Compassionate Use Act of 1996, which legalized medical marijuana in California, making it the first state to do so. The study followed other states as well and found that deaths from workplace accidents would drop about 34 percent after medical marijuana had been legal in that state for five years. The connection was most notable in the age group of 25- to 44-year-olds, which demonstrated a 19.8 percent reduction. Continue reading

A major victory in the fight for medical marijuana has finally arrived. Amedical marijuana marijuana-derived drug was recently approved by the FDA, making it the first of its kind. According to Washington Post, Epidiolex is a liquid anti-seizure drug which contains a purified cannabidiol, a non-psychoactive element in marijuana. CBD, as you likely know it as, only contains trace amounts of THC and does not create the “high” that so many marijuana naysayers point to as the defense for their outdated thinking.

CBD oil is commonly used for pain management, anxiety, addiction treatment, and now in a drug used for childhood epilepsy. Clinical trials of Epidiolex have shown better results without the severe side effects of epilepsy drugs already on the market. The drug has now been approved for patients 2 and older. Of course this is significant for families battling this debilitating disorder, but it also could be a groundbreaking moment for the rest of us as well.

Continue reading

Even though time and again we see stories of people whose health was positively affected by cannabis, we still medical marijuanaconstantly find those who insist on fighting this useful treatment and punishing those who need it. The latest story comes out of Georgia, where a high school football player has been told the medical treatment that controls his seizures will prevent him from pursuing his dreams, according to a CNN report.

The senior committed to Auburn University in Alabama next school year, but was later informed that he would not be allowed to play football while continuing to use CBD oil. Because the decision came down from NCAA, it also means he wouldn’t be able to play for any other NCAA school. NCAA guidelines state that players cannot have any tetrhydrocannabidinol, better known as THC, in their systems. This is the component of cannabis known for creating a high sensation. Because it remains in the system long after the high is gone, it’s difficult to test whether a person is was under the influence an hour ago or three days ago. Continue reading

As of now, only one establishment has been given Drug Enforcement Administration clearance to manufacture medical marijuanamarijuana for research: University of Mississippi. This is in spite of a 2016 decision to allow DEA to approve medical marijuana manufacturers for research purposes and dozens of applications to join the pool, according to a McClatchy article. But a bipartisan bill aims to break down some of the barriers currently standing in the way of necessary and groundbreaking research. HR-5634 would force an increase in the number of registered manufacturers producing cannabis “for legitimate research purposes.”

It also would lift restrictions on medical practitioners at the Department of Veteran Affairs, who as of now must follow federal law and are therefore not allowed to recommend cannabis to any of their patients. If passed, the bill would open the door to federally approved clinical trials for veterans seeking help through the VA. This is a crucial next step in the fight for medical marijuana legalization nationwide. Veterans have long reported relief for post-traumatic stress disorder symptoms through cannabis, but if they seek treatment through VA medical professionals, they cannot access medical marijuana, even if they live in one of the 29 states that have legalized medical use. Even Washington, D.C., has approved medical marijuana, despite being the epicenter of restricting marijuana nationwide. Continue reading

More concrete medical marijuana research is on the horizon thanks to grants awarded to two different universities by one foundation with the intent of advancing our understanding of cannabismedical marijuana treatments. University of Utah is planning a $740,000, two-year study on how marijuana affects the brain and why it affects some people differently. UC San Diego, meanwhile, received a cool $4.7 million to research the effects of cannabidiol (CBD) in the treatment of autism. The university said it is the largest private donation for medical cannabis research in U.S. history, according to KPBS.

Where the federal government has failed, The Ray and Tye Noorda Foundation is attempting to fill a need for more comprehensive medical cannabis research. The foundation says it donates sizable grants to projects it believes will help build a “world where all people enjoy equal opportunities to achieve health, purpose, and happiness.” Our medical marijuana attorneys certainly agree cannabis research fits the bill. Project subjects the foundation is funding also include chronic homelessness, economic advancement, housing and health initiatives, and re-entry into society after serving jail time, in addition to cannabis research.  Continue reading

Marijuana businesses have become a major competitor to beer and willmarijuana business lawyers continue to disrupt that industry for the foreseeable future.

An investment firm industry analyst, who specializes in beverages, tobacco, and adult-use marijuana, recently shared data with CNBC, and she established a clear correlation between increased use of marijuana and decreased use of alcohol. She said in states where recreational marijuana use is legal, binge drinking rates have dropped “significantly.” She identified both as “social lubricants.” In other words, both are used by adults in social situations to help unwind, de-stress, have a good time, and feel relaxed with new people or in new environments. 

In terms of stocks, the numbers are clear, as well. Her firm primarily valuates the Canadian market, with Canada on track to legalize adult-use marijuana nationwide by the end of summer. Several Canadian medical marijuana companies are seeing shares grow by up to 240 percent in the past year in anticipation. She said estimates from her firm put the U.S. cannabis industry as being worth $75 billion by 2030, assuming marijuana is removed as a Schedule I narcotic from the Controlled Substances Act, 21 U.S.C. Section 812. Continue reading

Contact Information